We studied the effects of supplemental dietary arginine (ARG) on endot
oxin-induced bacterial translocation. Mice were fed a 20%-casein diet
(control) or a 20%-casein diet supplemented with 2% or 4% ARG and then
injected with lipopolysaccharide (1 mg/500 mu l). The incidence of ba
cterial translocation was noted by the recovery of viable organisms fr
om the mesenteric lymph node (MLN) and spleen. The mortality rates of
the mice were 40%, 10%, and 20% in the control group and 2%- and 4%-AR
G groups, respectively. Of the surviving mice, bacterial translocation
occurred in 100% of the control group, in 56% (MLN) and 56% (spleen)
in the 2%-ARG group, and in 36% (MLN) and 25% (spleen) in the 4%-ARG g
roup. Quantitative colony counts and median numbers of viable bacteria
were lower (p < 0.05) in the 2%-ARG group and slightly lower in the 4
%-ARG group compared with the control group. MLN and spleen weights ex
pressed as a percentage of body weight were heavier (p < 0.05) only in
the 2%-ARG group. These results support the concept that bacteria may
translocate from the gut to other organs and be a potential source of
lethal infection after injury, and that supplementation with 2% or 4%
ARG could improve outcome.